AzTrials
AzTrials

Dyspnea; CardiacPArADIsENCT02800122

PAthwAy of Dyspneic patIent in Emergency (PArADIsE)

An observational study of Dyspnea; Cardiac and Acute Disease, run by CHOUIHED Tahar at 1 site in France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This is an observational retrospective single-center study (CHRU of Nancy) in patients cared for acute dyspnea by a medical team of the emergencies of the CHRU of Nancy. The main purpose of the study is to evaluate the outcome of patients cared for acute dyspnea by a medical team of emergencies of CHRU of Nancy. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Dyspnea; Cardiac, Acute Disease
How many people
24,000 participants
Where
1 siteFrance
Study dates
Mar 2016to 25 Oct 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients with acute dyspnea cared by a medical team of emergencies of CHRU Nancy in the last 5 years.

Who may be able to join

  • Man or women ≥ 18 years
  • Patients with acute dyspnea cared by a medical team of the emergencies of CHRU of Nancy.

Who cannot join

  • Cardiorespiratory arrest before the care by a medical team of the emergencies of the CHRU of Nancy.

Trial locations and contacts

1 site in 1 country.

Tahar CHOUIHED, MD, PhD contact

+ 33 3 83 15 73 88

t.chouihed@chru-nancy.fr

Nicolas GIRERD, MD, PhD contact

+33383157322

n.girerd@chru-nancy.fr

France1 site, 1 recruiting
  • CHRU Nancy - Service des Urgences

    Nancy, 54000

    Tahar CHOUIHED, MD, +33 3 83 85 14 96, t.chouihed@chru-nancy.fr

    Tahar CHOUIHED, MD

    Recruiting

Other trials in France

About this study

Official title: PAthwAy of Dyspneic patIent in Emergency

This is an observational retrospective single-center study (CHRU of Nancy) in patients cared for acute dyspnea by a medical team of the emergencies of the CHRU of Nancy.

The main purpose of the study is to evaluate the outcome of patients cared for acute dyspnea by a medical team of emergencies of CHRU of Nancy.

Read the detailed description

This observational retrospective single-center study will be conducted using data from medical records, acquired as part of usual care, patients cared for acute dyspnea in the last 5 years (from the date of authorization of data processing). About 4,000 patients will be affected, including more than 800 patients with acute heart failure.

Keywords
acute dyspnea, emergency, acute heart failure
Medical subject headings
Dyspnea, Acute Disease, Emergencies

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT02800122
Study groupRoleWhat they receive
Patients with acute dyspneaPatients with acute dyspnea treated by a medical team of emergencies of CHRU of Nancy. All patients admitted to the emergencies in the last 5 years matching the inclusion criteria will be evaluated. About 4,000 patients will be affected, including more than 800 patients with acute heart failure. (Figures based on export of ICD X codes (R06.0: Dyspnea) of patients cared in extra-hospital for acute dyspnea (diagnosis Dyspnea + Heart Failure) over the last 5 years).

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. All cause in-hospital mortality

    Measured: in the last 5 years

Secondary outcomes (9)
  1. Demographic and clinical data of patients cared by a medical team of emergencies

    Measured: in the last 5 years

  2. Duration of total hospitalization (including emergency stay and conventional hospitalization)

    Measured: in the last 5 years

  3. The main diagnosis of the initial hospitalization

    Measured: in the last 5 years

  4. Rate of Brain Natriuretic Peptide (BNP)

    Measured: in the last 5 years

  5. Administration of non-invasive ventilation and / or diuretics and / or nitrates

    Measured: in the last 5 years

  6. Administration time of non-invasive ventilation and / or diuretics and / or nitrates

    Measured: in the last 5 years

  7. Service type admitting the patient after the emergency care (intensive care, cardiology, intensive care cardiology, other ...)

    Measured: in the last 5 years

  8. Admission time in a service after the emergency care

    Measured: in the last 5 years

  9. Mortality and re-hospitalization of included patients

    Measured: in the last 5 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Jun 2016 (estimated)
  2. Study startMar 2016
  3. Primary completionDec 2018
  4. Study completion25 Oct 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
24,000 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02800122
Sponsor's protocol ID
R2016-08
Acronym
PArADIsE
Status last verified
Apr 2023
First submitted
6 Jun 2016
Last updated
18 Apr 2023
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Publications

  • Chouihed T, Bassand A, Duarte K, Jaeger D, Roth Y, Giacomin G, Delaruelle A, Duchanois C, Bannay A, Kobayashi M, Rossignol P, Girerd N. Head-to-head comparison of diagnostic scores for acute heart failure in the emergency department: results from the PARADISE cohort. Intern Emerg Med. 2022 Jun;17(4):1155-1163. doi: 10.1007/s11739-021-02879-6. Epub 2021 Nov 17.

    PubMed 34787803
  • Chouihed T, Buessler A, Bassand A, Jaeger D, Virion JM, Nace L, Barbe F, Salignac S, Rossignol P, Zannad F, Girerd N. Hyponatraemia, hyperglycaemia and worsening renal function at first blood sample on emergency department admission as predictors of in-hospital death in patients with dyspnoea with suspected acute heart failure: retrospective observational analysis of the PARADISE cohort. BMJ Open. 2018 Mar 30;8(3):e019557. doi: 10.1136/bmjopen-2017-019557.

    PubMed 29602842

Questions about this trial

What is this clinical trial studying?

An observational study of Dyspnea; Cardiac and Acute Disease, run by CHOUIHED Tahar at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 18 Apr 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Tahar CHOUIHED, MD, PhD (+ 33 3 83 15 73 88, t.chouihed@chru-nancy.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

All cause in-hospital mortality (time frame: in the last 5 years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02800122, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Apr 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in